Market Indices
Sector Heatmap
ALLR — Allarity Therapeutics, Inc. Common Stock
NasdaqAllarity Therapeutics, Inc. Common Stock
- O
- 1.06
- H
- 1.08
- L
- 1.01
- V
- 74K
ALLR — Latest News & Headlines
9 StoriesAllarity Therapeutics, Inc. (ALLR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Allarity Therapeutics, Inc. (ALLR) Stock Price, News, Quote & History Yahoo! Finance Canada
About 300 proteins involved in tumor signaling can now be studied at Allarity’s lab. - Stock Titan
About 300 proteins involved in tumor signaling can now be studied at Allarity’s lab. Stock Titan
Allarity Therapeutics, Inc. (ALLR) stock price, news, quote and history - au.finance.yahoo.com
Allarity Therapeutics, Inc. (ALLR) stock price, news, quote and history au.finance.yahoo.com
Allarity Therapeutics (ALLR) Stock Analysis Report | Financials & Insights - benzinga.com
Allarity Therapeutics (ALLR) Stock Analysis Report | Financials & Insights benzinga.com
Patents and a certified lab help Allarity retain sole control of its cancer test - Stock Titan
Patents and a certified lab help Allarity retain sole control of its cancer test Stock Titan
Allarity Therapeutics (ALLR) Gains 4.31% to $1.21, Pressing Toward Resistance at $1.27 - Covered Call Trade - siam.in
Allarity Therapeutics (ALLR) Gains 4.31% to $1.21, Pressing Toward Resistance at $1.27 - Covered Call Trade siam.in
Allarity Therapeutics, Inc. (ALLR) Latest Stock News & Headlines - Yahoo! Finance Canada
Allarity Therapeutics, Inc. (ALLR) Latest Stock News & Headlines Yahoo! Finance Canada
Allarity expands lab capabilities to support drug research By Investing.com - Investing.com Nigeria
Allarity expands lab capabilities to support drug research By Investing.com Investing.com Nigeria
ALLR Q2 2026 Earnings: Narrower-Than-Expected Loss, but Shares Slip - Dividend Growth Analysis - siam.in
ALLR Q2 2026 Earnings: Narrower-Than-Expected Loss, but Shares Slip - Dividend Growth Analysis siam.in